SK Bioscience Reports 29.2 Billion KRW Operating Loss in 1Q... Sales Down 76.4% YoY
Turned to Deficit Compared to Previous Year
![Aerial view of SK Bioscience R&PD Center. [Photo by SK Bioscience]](http://www.asiae.co.kr/news/img_view.htm?img=2023020816405917814_1675842059.jpg)
SK Bioscience announced on the 27th that it recorded an operating loss of 29.189 billion KRW on a consolidated basis for the first quarter of this year. This marks a turnaround to a loss compared to an operating profit of 23.752 billion KRW during the same period last year.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- One in 77 Koreans Exposed to Drugs... Enough Money for 6,600 Luxury Gangnam Apartments Circulates in Drug Market [ChwiYakGukga] ⑩
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
During the same period, sales amounted to 20.597 billion KRW, a 76.4% decrease compared to the previous year. Net loss for the period also reached 14.268 billion KRW, turning to a loss compared to the previous year.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
